Kim Kjøller

Company: UNION Therapeutics

Job title: Chief Executive Officer

Seminars:

Recent Trials in AD – Inconsistency Between Outcome Scales 11:55 am

Decreasing EASI baseline severity in recent years AD trial has led to very high placebo responses – Particularly in the moderate patient segment IGA and PGIC remain robust endpoints What can we learn, and can Biomarkers help substantiate which scale is the most appropriate Going forward – How do we face the EASI “Challenge” –…Read more

day: Day One Clinical Track AM